Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

Data as of Sep 22
 -0.24 / -3.77%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Conatus Pharmaceuticals, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel medicines to treat liver diseases. The company is engaged in developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Emricasan is a first-in-class, orally active caspase protease inhibitor designed to reduce the activity of enzymes that mediate inflammation and cell death, or apoptosis. Conatus Pharmaceuticals was founded by Alfred P. Spada, Jennifer Giottonini Cayer, Steven J. Mento and Charles J. Cashion on July 13, 2005 and is headquartered in San Diego, CA.

Contact Information

Conatus Pharmaceuticals, Inc.
4365 Executive Drive
San Diego California 92121
P:(858) 558-8130
Investor Relations:
(858) 457-7237



Individual stakeholders49.24%
Mutual fund holders12.16%
Other institutional12.04%

Top Executives

Steven J. MentoPresident, Chief Executive Officer & Director
Charles J. CashionChief Financial Officer, Secretary & SVP
Alfred P. SpadaCSO & Senior Vice President-Research & Development
Gary Craig BurgessChief Medical Officer & SVP-Clinical Research
Daniel L. RipleySenior Director & Head-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.